OptimizeRx to Present at RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020
The event aims to dig deeper across sectors into how the healthcare industry will emerge out of the COVID-19 pandemic, uncovering new approaches to innovation, such as digital health, future trends in industry collaboration and consolidation, and political and macro-economic influences.
The live presentation will be available at investors.optimizerx.com/events-and-presentations.
The event is for institutional clients of RBC and is by invitation only. To schedule a one-on-one meeting with
About
For more information, go to OptimizeRx.com, and follow the company on Twitter and LinkedIn.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
OptimizeRx Contact
Tel (248) 651-6568 x807
dbaker@optimizerx.com
Media Relations Contact
Tel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact
CMA Investor Relations
Tel (949) 432-7557
oprx@cma.team
Source: OptimizeRx Corporation